NEWS
euroPCR 2018 – TIDES-ACS trial

VIDEO INVESTIGATOR INTERVIEW

TIDES ACS is the first randomised trial to compare the novel Optimax bioactive stent against the Synergy drug eluting stent.

Optimax is a cobalt chromium metal stent with an active coating of titanium nitride oxide, and it is matched against an everolimus drug eluting stent, “the best drug eluting stent currently on the market”, believes investigator Parsi Karjalainen.

logo

SHARED VALUES

 

Primum non nocere. First do not harm


cercle_sharedvalues

PATIENT AREA

 

Everyone may one day need treatment for a clogged artery

 


cercle_patientarea

HEALTHCARE PROFESSIONALS

 

Improve life of patients affected with cardiovascular diseases

 


cercle_healthcare

HEXACATH EVENTS

25-29 August, 2018 - Munich, Germany.